Entrada Therapeutics, Inc. (TRDA)
NASDAQ: TRDA · IEX Real-Time Price · USD
8.46
-0.46 (-5.11%)
Jan 27, 2022 3:47 PM EST - Market open
Cash Flow Statement (Annual)
Millions USD. Fiscal year is Jan - Dec.
| Year | 2020 | 2019 |
|---|---|---|
| Net Income | -26.52 | -5.1 |
| Depreciation & Amortization | 0.33 | 0.1 |
| Share-Based Compensation | 0.33 | 0.29 |
| Other Operating Activities | 0.3 | -6.1 |
| Operating Cash Flow | -25.57 | -10.8 |
| Capital Expenditures | -2.32 | -0.63 |
| Investing Cash Flow | -2.32 | -0.63 |
| Share Issuance / Repurchase | 0.25 | 0.04 |
| Other Financing Activities | 49.84 | 0 |
| Financing Cash Flow | 50.09 | 0.04 |
| Net Cash Flow | 22.2 | -11.39 |
| Free Cash Flow | -27.89 | -11.43 |
| Free Cash Flow Per Share | -3.49 | -1.69 |
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).